The global Fibrinogen market was valued at US$ 689.2 million in 2020 and is expected to reach US$ 1866.7 million by the end of 2027, growing at a CAGR of 15.3% during 2021-2027.
Fibrinogen (factor I) is a glycoprotein in vertebrates that helps in the formation of blood clots. Fibrinogen Concentrate is used as a medicine for blood disease. Fibrinogen concentrate is a preparation of coagulation factors prepared from pooled plasma. Currently, only RiaSTAP (CSL Behring) is licensed in a number of countries for multiple indications including treating acute bleeding episodes with Hypofibrinogenemia. Other manufacturer’s products are justly used in local region or countries.
Global core fibrinogen manufacturers include CSL Behring, LFB Group and Shanghai RAAS Blood Products etc. The top 1 companies hold a share about 52%. North America is the largest market, with a share about 31%, followed by Europe and Asia Pacific with the share about 28% and 26%.
Global Fibrinogen Market: Drivers and Restrains
The research report has incorporated the analysis of different factors that augment the market’s growth. It constitutes trends, restraints, and drivers that transform the market in either a positive or negative manner. This section also provides the scope of different segments and applications that can potentially influence the market in the future. The detailed information is based on current trends and historic milestones. This section also provides an analysis of the volume of production about the global market and about each type from 2016 to 2027. This section mentions the volume of production by region from 2016 to 2027. Pricing analysis is included in the report according to each type from the year 2016 to 2027, manufacturer from 2016 to 2021, region from 2016 to 2021, and global price from 2016 to 2027.
A thorough evaluation of the restrains included in the report portrays the contrast to drivers and gives room for strategic planning. Factors that overshadow the market growth are pivotal as they can be understood to devise different bends for getting hold of the lucrative opportunities that are present in the ever-growing market. Additionally, insights into market expert’s opinions have been taken to understand the market better.
Global Fibrinogen Market: Segment Analysis
The research report includes specific segments by region (country), by manufacturers, by Type and by Application. Each type provides information about the production during the forecast period of 2016 to 2027.
Key Companies profiled in this report are CSL Behring, LFB Group, Shanghai Raas Blood Products, Jiangxi Boya Bio-Pharmaceutical, Hualan Biological Engineering, Harbin Pacific Biopharmaceutical, Green Cross, Shanghai XinXing Medical, Taibang Biologic, Octapharma and more in terms of market share by sales, revenue, average pricing, product type, margins, recent developments etc.
Find more details at: https://www.themarketreports.com/report/global-fibrinogen-market-outlook
Segment by Type
- Human Fibrinogen
- Animal Fibrinogen
Segment by Application
- Congenital Fibrinogen Deficiency
- Surgical Procedures
Table of Content:
1 Fibrinogen Market Overview
2 Fibrinogen Market Competition by Manufacturers
3 Fibrinogen Retrospective Market Scenario by Region
4 Global Fibrinogen Historic Market Analysis by Type
5 Global Fibrinogen Historic Market Analysis by Application
6 Key Companies Profiled
7 Fibrinogen Manufacturing Cost Analysis
8 Marketing Channel, Distributors and Customers
9 Fibrinogen Market Dynamics
10 Global Fibrinogen Market Forecast
11 Research Finding and Conclusion
12 Methodology and Data Source
Company Name: The Market Reports
Contact Person: Shirish Gupta